CLINICAL_TRIALS
trial_result
· 2025-12-18
Clinical Trial Update: A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Lupus Nephritis (ZL-1103-013) [Phase 2]
Summary
A Phase 2 clinical trial evaluating the effectiveness and safety of efgartigimod in Chinese patients with lupus nephritis has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: argenx | Conditions: Lupus Nephritis | Phase 2 | Status: COMPLETED